» Shortlist dei candidati - Farmaci
• Alexion - Ravulizumab (ULTOMIRIS®)
• Alexion - Eculizumab (SOLIRIS®)
• Alexion - Andexanet alfa (ONDEXXYA®)
• Gilead - Remdesivir (VEKLURY®)
• GW Pharma - Cannabidiolo
(EPIDYOLEX®)
• Incyte - Pemigatinib (PEMAZYRE®)
• JAZZ Pharmaceuticals - Solriamfetol
(SUNOSI®)
• Kyowa Kirin - mogamulizumab
• MSD - Doravirina e Doravirina/Lamivudina/Tenofovir disoproxil fumarato
(DELSTRIGO®/PIFELTRO®)
• MSD- Imipenem/cilastatina/relebactam (RECARBRIO®)
• MSD - Vaccino contro virus Ebola (ERVEBO®)
• Novartis - Dabrafenib/trametinib (TAFINLAR® /MEKINIST®)
• Novartis Gene Therapies - Onasemnogene abeparvovec (ZOLGENSMA®)
• Roche - Entrectinib (ROZLYTREK®)
• Roche - Risdiplam (EVRYSDI®)
• Roche – Trastuzumab (HERCEPTIN®)
• Sanofi Pasteur - Antinfluenzale quadrivalente (EFLUELDA®)
• Sanofi Pasteur - Antinfluenzale quadrivalente (SUPEMTEK®)
• Vertex Pharmaceuticals - Ivacaftor/tezacaftor/elexacaftor (KAFTRIO®)
» Shortlist dei candidati - Medical Devices
• IBSA - SINOGEL®
• Moveo - ExoBand®
• Nimble Robotics - REHO®
» Shortlist dei candidati – Terapie digitali
• Medtronic - Sistema MINIMED™
• Novartis - Enerzair® Breezhaler® (QVM149)
• Roche Diabetes Care - MySugr®
